Operating Data

CytRx Corporation (CYTR)

$ 3.09
0.25 (+8.80%)
Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 0.300.100.100.200.100.250.330.440.590.791.051.401.87
Revenue (%)
EBITDA -27.47-49.42-62.96-51.72-32.24-8.22-7.84-6.60-138.35-184.46-245.95-327.93-437.25
EBITDA (%)
EBIT -27.59-49.61-63.28-52.26-32.87-8.25-7.86-6.83-139.46-185.95-247.94-330.58-440.78
EBIT (%)
Depreciation 0.120.180.320.540.630.030.020.231.121.491.992.653.53
Depreciation (%)




EBIT (Operating profit)(Operating income)(Operating earning) = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT)
EBIT = (1*) (2*) -> operating process (leverage -> interest -> EBT -> tax -> net Income)
EBITDA = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT) + Depreciation + amortization
EBITA = (1*) (2*) (3*) (4*) company's CURRENT operating profitability (i.e., how much profit it makes with its present assets and its operations on the products it produces and sells, as well as providing a proxy for cash flow) -> performance of a company
(1*) discounting the effects of interest payments from different forms of financing (by ignoring interest payments),
(2*) political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill)
(3*) collections of assets (by ignoring depreciation of assets)
(4*) different takeover histories (by ignoring amortization often stemming from goodwill)